Search
for
Sort by
Research 601–630 of 775
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Transcription factor-based transdifferentiation of human embryonic to trophoblast stem cells
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Prostaglandins: Key players in immunomodulation of the nervous system
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Disease-related biomarkers as experimental endpoints in 3D skin culture models
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series
- Molecular mediators involved in skin healing: a narrative review
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Extracellular Vesicles in Skin: Biological Function and Therapeutic Potential
- JAK inhibition decreases the autoimmune burden in Down syndrome
- N6-methyladenosine (m6A)-circHECA from secondary hair follicle of cashmere goats: identification, regulatory network and expression regulated potentially by methylation of its host gene promoter
- Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Gut microbiome, metabolome and alopecia areata